ESMO 2012 News

Welcome to ESMO 2012 news. Here you will find a selection of articles that appeared in the ESMO 2012 newspaper, Congress Daily, which was distributed to attendees of the ESMO congress in Vienna.

Complete copies of the four newspapers are available for download as PDF files


Date Title Topic
01 Oct 2012 New weapons in the fight against cancer
30 Sep 2012 Dual therapy shows potential in melanoma Melanoma
30 Sep 2012 ESMO holds first session dedicated to Community Oncologists Anticancer agents & Biologic therapy
30 Sep 2012 Imaging biomarkers in the era of targeted therapies Imaging
30 Sep 2012 Novel hypoxia drug shows promise in pancreatic cancer Gastrointestinal cancers
30 Sep 2012 Case for including patients with brain metastases in clinical trials Head and neck cancers
30 Sep 2012 Patient rights and obligations Bioethics, legal and economic issues
30 Sep 2012 ARADES: A first-in-man study of ODM-201 Genitourinary cancers
30 Sep 2012 Analysis of NeoALTTO trial data: Too few women being offered breast-conserving treatment Breast cancer
30 Sep 2012 Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK-positive advanced NSCLC Lung and other thoracic tumours
30 Sep 2012 EXPAND study shows no benefit from adding cetuximab to the first-line chemotherapy in advanced gastric cancer Gastrointestinal cancers
30 Sep 2012 Survey reveals ‘global pandemic’ of untreated cancer pain Personalised medicine - Palliative and supportive care
30 Sep 2012 Family cancer histories prove challenging Personalised medicine
29 Sep 2012 Clever drugs for clever cancers Gastrointestinal cancers - Anticancer agents & Biologic therapy
29 Sep 2012 Four ongoing, early stage trials evaluate novel agents in NSCLC patients with ALK-positive and EGFR mutated tumours Lung and other thoracic tumours